Concepedia

Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy

Alexander Benton, Jia‐Geng Liu, Mathilde Poussin, Andrea Lang Goldgewicht, Madhara Udawela, Adham S. Bear, Nils Wellhausen, Beatriz M. Carreno, Matthew D. Beasley, Ben R. Kiefel,

Cancer Cell · 2025 · 23 citations · 45 references

DOIFull text

Open access

Concepts

References

45

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text

, , +17

Defining a Cancer Dependency Map

Aviad Tsherniak, Francisca Vázquez, Phil Montgomery et al. · Cell · 2017 · 3.5K citations · Full text

, , +1

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson et al. · The Lancet · 2014 · 2.9K citations

, , +17

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

Richard A. Morgan, James C. Yang, Mio Kitano et al. · Molecular Therapy · 2010 · 2.5K citations · Full text

, , +17

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

James N. Kochenderfer, Wyndham H. Wilson, John E. Janik et al. · Blood · 2010 · 1.3K citations · Full text

, , +14